Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (36 ops.)
Latest filing published 29 Sept 2026 for Revolution Medicines, Inc., €139k. Read the official filing
Filing timeline
BuySaleJeff Cislini
Insider track record
Disclosed buys
0
Disclosed sells
36
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jeff Cislini: trading record in brief
Jeff Cislini discloses dealings in Revolution Medicines, Inc. to SEC (Form 4). Over a trading history stretching from 20 June 2023 to 25 September 2026, the count stands at 45 filings.
No open-market purchase appears, only 36 sales worth €12.6M. No amount is published for 1 filing, which the totals therefore leave out. Other entries cover 3 share grants and 6 option exercises. In 2026 alone, the filings show no purchases and 12 sales.
The latest filing, published on 29 September 2026, reports an open-market sale of €139k in Revolution Medicines, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jeff Cislini
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations45 total
765 shares@ US$207.3201Common StockSEC:0001969082-26-000011:0
52 shares@ US$195.00870.1% of flowCommon StockSEC:0001969082-26-000009:0
3,314 shares@ US$199.30323.7% of flowCommon StockSEC:0001969082-26-000009:1
29,680 shares@ US$18.563.0% of flowCommon StockSEC:0001610717-26-000388:0
26,600 shares@ US$21.613.2% of flowCommon StockSEC:0001610717-26-000388:1
3,400 shares@ US$207.23633.9% of flowCommon StockSEC:0001610717-26-000388:2
17,323 shares@ US$208.368819.9% of flowCommon StockSEC:0001610717-26-000388:3
25,817 shares@ US$209.249729.8% of flowCommon StockSEC:0001610717-26-000388:4
2,540 shares@ US$210.26472.9% of flowCommon StockSEC:0001610717-26-000388:5
4,500 shares@ US$211.34175.2% of flowCommon StockSEC:0001610717-26-000388:6
3,314 shares@ US$212.05833.9% of flowCommon StockSEC:0001610717-26-000388:7
2,157 sharesCommon StockSEC:0001610717-26-000245:0
1,795 shares@ US$99.48041.0% of flowCommon StockSEC:0001610717-26-000127:0
14,500 shares0Common StockSEC:0001610717-26-000080:0
908 shares@ US$115.600.6% of flowCommon StockSEC:0001610717-26-000018:0
2,688 shares@ US$76.81691.1% of flowCommon StockSEC:0001610717-25-000424:0
13,388 shares@ US$42.453.2% of flowCommon StockSEC:0001610717-25-000383:0
12,000 shares@ US$36.572.4% of flowCommon StockSEC:0001610717-25-000368:0
1,799 shares@ US$44.260.4% of flowCommon StockSEC:0001610717-25-000353:0
1,869 shares@ US$45.82490.5% of flowCommon StockSEC:0001610717-25-000347:0
1,912 shares@ US$39.61080.4% of flowCommon StockSEC:0001610717-25-000250:0
1,878 shares@ US$39.830.4% of flowCommon StockSEC:0001610717-25-000240:0
2,041 shares@ US$38.71050.5% of flowCommon StockSEC:0001610717-25-000088:0
1,458 shares@ US$39.04030.3% of flowCommon StockSEC:0001610717-25-000081:0
22,000 shares0Common StockSEC:0001610717-25-000056:0
25 of 45 declarations
